Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) and keeping the price ...

Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

David Risinger’s rating is based on several key considerations surrounding AbbVie’s recent clinical trial outcomes. The company’s announcement on November 11, 2024, revealed that emraclidine’s Phase 2 ...

Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies ...

(Bloomberg) -- Oil steadied near $72 a barrel with prices broadly stuck in a narrow band as traders weigh the outlook for ...

In this update, I'll focus on Organon's Q3 2024 results, earnings adjustments and segment performance, as well as the ...

The Synlogic Board of Directors has not set a timetable for the conclusion of this review, nor has it made any decisions related to any further actions or potential strategic options at this time.

Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET. Company Participants. John Ciroli - Chief Legal Officer & Secretary Sean McCl ...

The Food and Drug Administration (FDA) recently gave Apple the green light to use software that may help million of people ...

How do I know I can trust these reviews about Renewal by Andersen? How do I know I can trust these reviews about Renewal by Andersen? 4,552,666 reviews on ConsumerAffairs are verified. We require ...